Show simple item record

dc.contributor.authorBashir, Aqib
dc.contributor.authorMorrissey, Hana
dc.contributor.authorBall, Patrick
dc.date.accessioned2018-05-22T14:45:00Z
dc.date.available2018-05-22T14:45:00Z
dc.date.issued2018-04-28
dc.identifier.citationBashir, A., Morrissey, H., Ball, PA. 'Systematic review of the efficacy of pharmacological treatment alone vs. psychotherapy alone or the combination of both in the treatment of depressive disorders' International Journal of Current Medical and Pharmaceutical Research, 4(4a) pp.3198-3207 doi: 10.24327/23956429.ijcmpr20180426
dc.identifier.issn2395-6429
dc.identifier.doi10.24327/23956429.ijcmpr20180426
dc.identifier.urihttp://hdl.handle.net/2436/621297
dc.description.abstractDepression is a challenging condition to treat especially where the efficacy of the current types of treatments has been in debate for decades. The aim of this review was to compare the effectiveness of medications to psychotherapy interventions and the combination of both interventions in the treatment of depression. This was conducted by evaluating the evidence from studies that investigated the efficacy of alone interventions and dual therapy to identify the best course of treatment for depression. Twenty studies were selected of which ten were directly compared pharmacotherapy with psychotherapy and a further ten compared the combination of both to either of the two monotherapies. The results showed that in either of monotherapies cohorts, the rates of response, remission and changes in symptom severity were near equivalent for both but dropout rates were higher for the medications groups. Comparing dual therapy to the monotherapies showed higher efficacy in terms of response, remission and reduction of symptom severity for combination. The difference however seen less with pharmacotherapy and showed psychotherapy being least effective but the difference was in efficacy is small in the majority of the studies, to a point in which the question of‘is the difference clinically significant’ remained unanswered which require more definitive future research.
dc.formatapplication/PDF
dc.language.isoen
dc.publisherInternational Journal of Current Medical and Pharmaceutical Research
dc.relation.urlhttp://journalcmpr.com/issues/systematic-review-efficacy-pharmacological-treatment-alone-vs-psychotherapy-alone-or
dc.subjectPharmacotherapy
dc.subjectpsychotherapy
dc.subjectcombination therapy
dc.subjectdepression
dc.subjectdepressive disorders
dc.titleSystematic review of the efficacy of pharmacological treatment alone vs. psychotherapy alone or the combination of both in the treatment of depressive disorders
dc.typeJournal article
dc.identifier.journalInternational Journal of Current Medical and Pharmaceutical Research
dc.date.accepted2018-03-24
rioxxterms.funderUniversity of Wolverhampton
rioxxterms.identifier.projectUOW22052018HM1
rioxxterms.versionAM
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/cc-by/4.0/
rioxxterms.licenseref.startdate2020-11-11
dc.source.volume4
dc.source.issue4
dc.source.beginpage3198
dc.source.endpage3207
refterms.dateFCD2018-10-19T09:24:44Z
refterms.versionFCDAM
refterms.dateFOA2018-08-20T16:11:33Z
html.description.abstractDepression is a challenging condition to treat especially where the efficacy of the current types of treatments has been in debate for decades. The aim of this review was to compare the effectiveness of medications to psychotherapy interventions and the combination of both interventions in the treatment of depression. This was conducted by evaluating the evidence from studies that investigated the efficacy of alone interventions and dual therapy to identify the best course of treatment for depression. Twenty studies were selected of which ten were directly compared pharmacotherapy with psychotherapy and a further ten compared the combination of both to either of the two monotherapies. The results showed that in either of monotherapies cohorts, the rates of response, remission and changes in symptom severity were near equivalent for both but dropout rates were higher for the medications groups. Comparing dual therapy to the monotherapies showed higher efficacy in terms of response, remission and reduction of symptom severity for combination. The difference however seen less with pharmacotherapy and showed psychotherapy being least effective but the difference was in efficacy is small in the majority of the studies, to a point in which the question of‘is the difference clinically significant’ remained unanswered which require more definitive future research.


Files in this item

Thumbnail
Name:
1204-A-2018.pdf
Size:
1.089Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/cc-by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/cc-by/4.0/